Q05397

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession FAK1_HUMAN; Q05397;
Entrez ID 5747
GenBank Protein ID NM_001199649.1; NM_153831.3; XM_017013673.1;
GenBank Nucleotide ID NP_001186578.1; NP_722560.1; XP_016869162.1;
Protein Name Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)
Gene Name PTK2; FAK; FAK1
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionNon-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse form(view all)
Sequence
(Fasta)
MAAAYLDPNL NHTPNSSTKT HLGTGMERSP GAMERVLKVF HYFESNSEPT TWASIIRHGD 60
ATDVRGIIQK IVDSHKVKHV ACYGFRLSHL RSEEVHWLHV DMGVSSVREK YELAHPPEEW 120
KYELRIRYLP KGFLNQFTED KPTLNFFYQQ VKSDYMLEIA DQVDQEIALK LGCLEIRRSY 180
WEMRGNALEK KSNYEVLEKD VGLKRFFPKS LLDSVKAKTL RKLIQQTFRQ FANLNREESI 240
LKFFEILSPV YRFDKECFKC ALGSSWIISV ELAIGPEEGI SYLTDKGCNP THLADFTQVQ 300
TIQYSNSEDK DRKGMLQLKI AGAPEPLTVT APSLTIAENM ADLIDGYCRL VNGTSQSFII 360
RPQKEGERAL PSIPKLANSE KQGMRTHAVS VSETDDYAEI IDEEDTYTMP STRDYEIQRE 420
RIELGRCIGE GQFGDVHQGI YMSPENPALA VAIKTCKNCT SDSVREKFLQ EALTMRQFDH 480
PHIVKLIGVI TENPVWIIME LCTLGELRSF LQVRKYSLDL ASLILYAYQL STALAYLESK 540
RFVHRDIAAR NVLVSSNDCV KLGDFGLSRY MEDSTYYKAS KGKLPIKWMA PESINFRRFT 600
SASDVWMFGV CMWEILMHGV KPFQGVKNND VIGRIENGER LPMPPNCPPT LYSLMTKCWA 660
YDPSRRPRFT ELKAQLSTIL EEEKAQQEER MRMESRRQAT VSWDSGGSDE APPKPSRPGY 720
PSPRSSEGFY PSPQHMVQTN HYQVSGYPGS HGITAMAGSI YPGQASLLDQ TDSWNHRPQE 780
IAMWQPNVED STVLDLRGIG QVLPTHLMEE RLIRQQQEME EDQRWLEKEE RFLKPDVRLS 840
RGSIDREDGS LQGPIGNQHI YQPVGKPDPA APPKKPPRPG APGHLGSLAS LSSPADSYNE 900
GVKLQPQEIS PPPTANLDRS NDKVYENVTG LVKAVIEMSS KIQPAPPEEY VPMVKEVGLA 960
LRTLLATVDE TIPLLPASTH REIEMAQKLL NSDLGELINK MKLAQQYVMT SLQQEYKKQM 1020
LTAAHALAVD AKNLLDVIDQ ARLKMLGQTR PH 1053

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/HepatomaP11287749
[Reference]: Protein kinase C-mediated tyrosine phosphorylation of paxillin and focal adhesion kinase requires cytoskeletal integrity and is uncoupled to mitogen-activated protein kinase activation in human hepatoma cells.
2PhosphorylationCervical cancer/carcinomaP24058594
[Reference]: The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC
3PhosphorylationHead and neck squamous cell carcinomaU22483702
[Reference]: Focal adhesion kinase (FAK), a main regulator of integrin signaling and cell migration, is frequently overexpressed and hyperphosphorylated in human head-and-neck squamous cell carcinoma (HNSCC)
4PhosphorylationBreast cancer/tumor/carcinomaU12421874
[Reference]: In metastatic ER-negative MDA-MB-231 cells, all estrogenic compounds tested increased Akt and FAK phosphorylation.
5Tyrosine PhosphorylationLung cancer/carcinomaDY39723799510
[Reference]: intensity levels of total FAK and pY397-FAK were decreased in the FAK-heterozygous cells
6Tyrosine PhosphorylationSkin cancerDY39723799510
[Reference]: intensity levels of total FAK and pY397-FAK were decreased in the FAK-heterozygous cells
7Tyrosine PhosphorylationColon cancer/carcinomacell lineDY39712871985
[Reference]: pY407 and pY397 of FAK decrease as tumors go from well differentiated to poorly (correlation r=0.9). No correlation with pY576, pY577, pY861, and pY925 and tumor differentiation.
8Tyrosine PhosphorylationGastric cancerPY39723109808
[Reference]: Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901
9Tyrosine PhosphorylationMelanomaPY39724098450
[Reference]: his result suggests that lumcorin may also inhibit melanoma cell migration by involvement of FAK phosphorylation
10Tyrosine PhosphorylationGlioblastomacell linePY39723243059
[Reference]: Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide
11Tyrosine PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/Hepatomacell linePY39723525457
[Reference]: Prostaglandin E receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells
12Tyrosine PhosphorylationSquamous cell carcinomaUY39714603053
[Reference]: FAK and phospho-FAK are overexpressed in squamous cell carcinoma of the larynx. FAK expression correlates with differentiation. Future investigations will examine the potential of FAK and FAK pY397 expression both as a prognostic indicator and a point of therapeutic inhibition.
13Tyrosine PhosphorylationOvarian cancer/carcinomaUY39724062525; 24655477
[Reference]: High pY397 FAK is associated with improved overall survival;Kaplan Meier curves for overall survival time showed that high tumor expression of FAK and YB-1 were associated with higher ovarian cancer mortality
14Tyrosine PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/HepatomaUY39720180147
[Reference]: Phosphorylated Y379 is overexpressed in hepaocellular carcinoma, and correlated with tumor stage, vascular invasion, and intrahepatic metastasis,
15Tyrosine PhosphorylationLung squamous cell carcinomaUY39723906871
[Reference]: The level of P-FAK expression in LSCC was significantly higher than the level in the ANCT
16Tyrosine PhosphorylationOral squamous cell carcinomaUY39722766511
[Reference]: We found that phosphorylated FAK was highly expressed in human tongue oral squamous cell carcinoma in patients
17Tyrosine PhosphorylationBreast cancer/tumor/carcinomaCY39724360952
[Reference]: We demonstrated that the expression of Tyr397 (main auto-phosphorylation of FAK) was strongly increased in FAK-Del33 overexpressed breast tumor cells compared to wild-type following FAK/Src RTK signaling activation
18Tyrosine PhosphorylationColon cancer/carcinomaDY40712871985
[Reference]: pY407 and pY397 of FAK decrease as tumors go from well differentiated to poorly (correlation r=0.9). No correlation with pY576, pY577, pY861, and pY925 and tumor differentiation.
19Tyrosine PhosphorylationX-linked agammaglobulinemiaUY57622366891
[Reference]: The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils.
20Serine PhosphorylationProstate cancer/carcinoma/adenocarcinomaUS72223785446
[Reference]: Triol treatment caused increased expression of E-cadherin protein levels but decreased expression of N-cadherin, vimentin, Slug, FAK, phospho-FAK Ser722, and phospho-FAK Tyr861 protein levels
21Serine PhosphorylationBreast cancer/tumor/carcinomaPS73224121667; 24115647
[Reference]: We further demonstrated that CDK5 modulated cancer cell migration and tumor formation by regulating the phosphorylation of FAK at Ser-732
22DephosphorylationBladder cancerUY86122353809
[Reference]: High expression of dephosphorylated Y(527), phosphorylated Y(416) and phosphorylated FAK Y(861) in the membrane were associated with increased cancer-specific survival (P=0. 01, P=0.001, P=0.008, respectively) and expression of Y(416) in the membrane was an independent factor on multivariate analysis when combined with known clinical parameters
23Tyrosine PhosphorylationProstate cancer/carcinoma/adenocarcinomaUY86123785446; 25868388
[Reference]: Triol treatment caused increased expression of E-cadherin protein levels but decreased expression of N-cadherin, vimentin, Slug, FAK, phospho-FAK Ser722, and phospho-FAK Tyr861 protein levels;correlates with decreased survival
24Tyrosine PhosphorylationColon cancer/carcinomaDY92515958584
[Reference]: Phosphorylation of Tyr(925) of focal adhesion kinase, a Src substrate, was reduced by similar concentrations of inhibitor.?

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 8)
(view all)
MESH:D001172 ; Arthritis, Rheumatoid
MESH:D006528 ; Carcinoma, Hepatocellular
MESH:D002294 ; Carcinoma, Squamous Cell
MESH:D002471 ; Cell Transformation, Neoplastic
MESH:D005909 ; Glioblastoma
MESH:D008325 ; Mammary Neoplasms, Experimental
GWASdb
(count: 33)
(view all)
rs10088475; Brain structure; Alzheimer's disease
rs13273096; Brain structure; Alzheimer's disease
rs7016497; Multiple complex diseases; Null
rs11166992; Brain structure; Alzheimer's disease
rs3639; Brain structure; Alzheimer's disease
rs4413752; Brain structure; Alzheimer's disease

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 67)
(view all)
1007      KMKLAQQYVMTSLQQ     dbPAF
1016      MTSLQQEYKKQMLTA     dbPAF
13        LDPNLNHTPNSSTKT     dbPAF
148       KPTLNFFYQQVKSDY     dbPAF
155       YQQVKSDYMLEIADQ     dbPAF
16        NLNHTPNSSTKTHLG     dbPAF
Sumoylation
(count: 1)
152       NFFYQQVKSDYMLEI     PLMD
Malonylation
(count: 1)
222       VKAKTLRKLIQQTFR     PLMD